Journal of Parkinson's Disease


Publication Venue For

  • Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel.  12:917-926. 2022
  • Preventing Parkinson's Disease: An Environmental Agenda.  12:45-68. 2022
  • Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.  12:557-570. 2022
  • Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.  12:421-436. 2022
  • Taking the Time to Assess Cognition in Parkinson's Disease: The Clock Drawing Test.  12:713-722. 2022
  • Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's Disease.  11:703-714. 2021
  • Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed in Person.  10:677-691. 2020
  • Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.  10:665-675. 2020
  • Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson's disease in rodents.  8:303-322. 2018
  • Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.  7:117-127. 2017
  • The role of stress as a risk factor for progressive supranuclear palsy.  7:377-383. 2017
  • Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.  6:741-749. 2016
  • Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.  5:1-19. 2015
  • A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease.  4:361-373. 2014